A5030559353- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Acute Ischemic Stroke Management
- Ultrasound in Clinical Applications
- Acute Myocardial Infarction Research
- Innovations in Medical Education
- Sepsis Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Cardiac Arrest and Resuscitation
- Global Health Workforce Issues
- Pharmaceutical Practices and Patient Outcomes
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Blood Pressure and Hypertension Studies
- Diagnosis and Treatment of Venous Diseases
- Medical Education and Admissions
- Hemodynamic Monitoring and Therapy
- Lipid metabolism and disorders
- Health and Medical Research Impacts
- Transplantation: Methods and Outcomes
- Cardiovascular Syncope and Autonomic Disorders
- Hematological disorders and diagnostics
- Mechanical Circulatory Support Devices
- Opioid Use Disorder Treatment
- Migraine and Headache Studies
- Non-Invasive Vital Sign Monitoring
Loyola University Chicago
2019-2023
Loyola University Medical Center
2018-2022
Rush University Medical Center
2021
Columbia University Irving Medical Center
2020
Massachusetts General Hospital
2019
Midwestern University
2017
Intermediate-risk pulmonary embolism (PE) has variable outcomes. Current risk stratification models lack the positive predictive value to identify patients at highest of PE-related mortality. We identified intermediate-risk PE who underwent catheter-based interventions and right heart catheterization (RHC) those with low cardiac index (CI < 2.2 L/min/m2). utilized regression echocardiographic predictors CI Kaplan Meier curve evaluate mortality when stratified by predictor. Of 174 patients,...
Acute pulmonary embolism (PE) is a heterogeneous disease process with variable presentation and outcomes. The endogenous fibrinolytic system complex framework of regulatory pathways that maintains homeostasis by dissolving overabundant thrombi. We sought to investigate phenotypic profiles the among patients presenting acute PE their impact on mortality.We enrolled all consecutive in our institutional Pulmonary Embolism Response Team registry. collected blood samples at time diagnosis...
Acute pulmonary embolism (PE) is a potentially life-threatening manifestation of venous thromboembolic disease. Severe acute respiratory syndrome-coronavirus-2, novel coronavirus that causes disease-2019 (COVID-19), has been associated with an increased risk thrombosis. We describe the therapeutic challenges 3 patients presenting PE and suspected or confirmed COVID-19. (Level Difficulty: Beginner.)
Background: Letters of recommendation (LORs) are a critical component for differentiating among similarly qualified pharmacy residency candidates. These letters contain information that is difficult to ascertain from curricula vitae and school transcripts. LOR writers may use any words or phrases appropriate each candidate as there no set framework LORs. Objective: The objective this study was characterize descriptive themes in postgraduate year 1 (PGY-1) candidates’ LORs examine which PGY-1...
Anticoagulation remains the mainstay pharmacotherapy for acute pulmonary embolism (PE), but multiple treatment options exist. The Pulmonary Embolism Response Team (PERT) is a multidisciplinary group that evaluates patients, formulates evidence-based plans, and mobilizes resources. objective of this study was to characterize anticoagulation prescribing patterns made by PERT determine clinical impact anticoagulant selection.This retrospective analysis patients evaluated from 2016 2018....
Risk stratification of acute pulmonary embolism (PE) is important to identify patients at risk for hemodynamic collapse who would benefit from more aggressive therapies. Angiopoietin-2 (Ang-2) a signaling molecule involved in angiogenesis and upregulated response tissue hypoxia. We aimed assess the association Ang-2 with (1) PE severity, (2) echocardiographic invasive markers right ventricular (RV) dysfunction, (3) need intensive treatment. Patients presenting our institution were included...
Factor Xa (fXa) inhibitor reversal for life-threatening bleeding is controversial due to a lack of high-quality evidence. The purpose this study was determine the hemostatic efficacy four-factor prothrombin complex concentrate (4F-PCC) fXa inhibitors compared warfarin bleeding.This multicenter, retrospective cohort at two academic medical centers between January 1, 2014-December 31, 2019, which included patients who presented emergency department with bleed necessitating anticoagulation...
The authors test the hypothesis that isolated-episode temporal patterns of ST changes result from sporadic physical activity and increased oxygen demand, salvo are due to vascular/endothelial factors in context coronary vasoconstrictions or vasospasms. used an adaptive autoregressive method study frequency-domain sympatho-vagal correlates neuro-autonomic control during transient ischemia for two very different groups records European Society Cardiology ST-T database: a group containing...
Newsome, Andrea1; Rech, Megan2; Hammond, Drayton3; Liang, Edith4; Masic, Dalila5; Vilella, Antonia6; Smith, Melanie7; Plewa-Rusiecki, Angela8; Heavner, Mojdeh9; Dzierba, Amy10; Blackwell, Sarah11; Flannery, Alexander12; Shah, Poorvi13; Zachary14; Horng, Michelle15; Radosevich, John16; Hassig, Tanna17; Campbell, Joshua18; Montero, Jennifer19; PHARM-CRIT Study Investigators SCCM Author Information
Copyright © 2018 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.